Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure
Lisinopril (angiotensin converting enzyme inhibitor) and valsartan (angiotensin II receptor blocker) are the first-line treatment for patients with congestive heart failure (CHF). These two drugs potentially cause side effects on renal functions. However, limited information was available regarding...
Saved in:
Main Authors: | Sarini Pani (Author), Melisa I. Barliana (Author), Eli Halimah (Author), Venice Chaeriadi (Author), Mally G. Sholih (Author) |
---|---|
Format: | Book |
Published: |
Universitas Padjadjaran,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Congestive Heart Failure in Diphtheric Myocarditis
by: A. M. Prasodo, et al.
Published: (2019) -
CONGESTIVE HEART FAILURE: EXPERIMENTAL MODEL
by: Antonio Francesco Corno, et al.
Published: (2013) -
Clinical and Humoral Determinants of Congestion in Heart Failure: Potential Role of Adiponectin
by: Luca Monzo, et al.
Published: (2019) -
Congestive Heart Failure in Newborns (Part 2)
by: L.V. Kolyubakina, et al.
Published: (2012) -
Role of Diuretics and Ultrafiltration in Congestive Heart Failure
by: Jo Ann Lindenfeld, et al.
Published: (2013)